PHS
EXAR

PFM Health Sciences’s Exar Corporation EXAR Stock Holding History

PFM Health Sciences’s Portfolio EXAR Stock Details EXAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-54,263
Closed -$531K – 109
2015
Q2 		$531K Buy
+54,263
New +$567K 0.01% 86

Other funds holding EXAR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PFM Health Sciences's EXAR Position: Q3 2015 in Review

PFM Health Sciences sold out of Exar Corporation (EXAR) in Q3 2015, closing a stake of 54,263 shares — an estimated $531K sold.

PFM Health Sciences first reported a position in EXAR in Q2 2015 and held it in 1 quarter. The position peaked at $531K in Q2 2015. 107 funds tracked by Wall St. Rank hold EXAR as of Q3 2015.

  • PFM Health Sciences reported no remaining Exar Corporation position as of Q3 2015 after selling out during the quarter.
  • PFM Health Sciences sold 54,263 Exar Corporation shares in Q3 2015, an estimated $531K.
  • PFM Health Sciences first reported a position in Exar Corporation in Q2 2015 and held it in 1 quarter.
  • PFM Health Sciences's Exar Corporation position peaked at $531K in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Exar Corporation as of Q3 2015.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.